Abstract:Morphine can promote the pathogenesis of human acquired immunodeficiency syndrome through binding to the mu opioid receptor (MOR) in immune cells. Previous investigation has suggested that expression of the MOR gene in lymphocytes is triggered by cooperative interaction between transcription factors, specificity protein 1 (Sp1) and Ying Yang 1 (YY1), in the promoter region. However, the specific molecular mechanism by which immunodeficiency virus infection impacts regulation of the MOR gene expression in lymphocytes is still unclear. In this study, it was demonstrated that SIV (SIVmac239) infection may result in gradual reduction of the MOR gene expression and Sp1 during a period of 48 h postinfection by analysis of quantitative real-time RT-PCR and Western blotting. The results of methylation-specific PCR showed that two of 14 CpG islands adjacent to the Sp1 and YY1 elements in the promoter region were methylated, which together with reduced Sp1, contributed to the failure of interaction of Sp1 with YY1 and their binding to the elements, as determined by coimmunoprecipitation, chromatin immunoprecipitation-real-time PCR, and EMSAs. The repression of the MOR gene secondary to SIVmac239 infection could be abolished by the demethylating agent 5-aza-2'-deoxycytidine. Transfection with Sp1-expressing vector (PN3-Sp1) was also able to enhance the activity of the promoter in SIVmac239-infected cells. We therefore concluded that aberrant methylation of the promoter and reduction of Sp1 resulting from SIVmac239 infection led to the silencing of the MOR gene. This finding will be helpful in understanding the synergistic mechanism of HIV infection and morphine addiction in the pathogenesis of AIDS. J. Leukoc. Biol. 85: 684-691; 2009.

The Potential Promoter Regions on the 5 ' Flank Sequence of the Mu Opioid Receptor Gene in Lymphocytes

The role of transcription factors Sp1 and YY1 in proximal promoter region in initiation of transcription of the mu opioid receptor gene in human lymphocytes.

Increased Methylation of the MOR Gene Proximal Promoter in Primary Sensory Neurons Plays a Crucial Role in the Decreased Analgesic Effect of Opioids in Neuropathic Pain

Mechanisms involved in phosphatidylinositol 3-kinase pathway mediated up-regulation of the mu opioid receptor in lymphocytes.

Morphine Modulates the Expression of Mu-Opioid Receptor Exon 5-Associated Full-Length C-terminal Splice Variants by Upregulating Mir-378A-3p

Inducible expression of functional mu opioid receptors in murine dendritic cells

The Opioid Ligand Binding of Human Mu-Opioid Receptor is Modulated by Novel Splice Variants of the Receptor.

Involvement of STAT5a Signaling in Morphine-Induced Up-Regulation of the Cyclin D1.

Alternative Pre-mRNA Splicing of the Mu Opioid Receptor Gene, OPRM1: Insight into Complex Mu Opioid Actions

Computational Insights into the Molecular Mechanisms of Differentiated Allosteric Modulation at the Mu Opioid Receptor by Structurally Similar Bitopic Modulators

Mediation of Opioid Analgesia by a Truncated Six Transmembrane G‐Protein‐Coupled Receptor

Homology modeling and molecular dynamics simulations of the mu opioid receptor in a membrane-aqueous system.

Behavioral and cellular pharmacology characterization of 17-cyclopropylmethyl-3,14β-dihydroxy-4,5α-epoxy-6α-(isoquinoline-3'-carboxamido)morphinan (NAQ) as a mu opioid receptor selective ligand.

Morphine Regulates Expression Ofμ-Opioid Receptor MOR-1A, an Intron-Retention Carboxyl Terminal Splice Variant of Theμ-Opioid Receptor (OPRM1) Gene Via Mir-103/Mir-107

Alternatively Spliced Mu Opioid Receptor C Termini Impact the Diverse Actions of Morphine

Opioid-induced Regulation of Gene Expression in PC12 Cells Stably Transfected with Mu-Opioid Receptor.

The role of nuclear factor kappaB in tumor necrosis factor-regulated transcription of the human mu-opioid receptor gene

Mu-Opioid Receptor Activation in Live Cells

The Mechanism Involved in the Repression of the Mu Opioid Receptor Gene Expression in Cem X 174 Cells Infected by Simian Immunodeficiency Virus

Mediation of Opioid Analgesia by a Truncated 6-Transmembrane GPCR.

mu-Opioid receptor activation enhances DNA synthesis in immature oligodendrocytes